Cargando…
A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations( )
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused significant mortality, especially among older adults whose distinct immune system reflects immunosenescence. Multiple SARS-CoV-2 vaccines have received emergency use authorization and/or licensure from the US Food a...
Autores principales: | Dowling, David J, Levy, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129145/ https://www.ncbi.nlm.nih.gov/pubmed/35512145 http://dx.doi.org/10.1093/cid/ciac342 |
Ejemplares similares
-
Precision Vaccine Adjuvants for Older Adults: A Scoping Review( )
por: Nanishi, Etsuro, et al.
Publicado: (2022) -
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )
por: Weitzman, Elissa R, et al.
Publicado: (2022) -
Precision Vaccines: Lessons Learned From the Coronavirus Pandemic( )
por: Angelidou, Asimenia, et al.
Publicado: (2022) -
Advancing Precision Vaccinology by Molecular and Genomic Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 in Germany, 2021( )
por: Oh, Djin Ye, et al.
Publicado: (2022) -
Perinatally Human Immunodeficiency Virus–Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity( )
por: Morrocchi, Elena, et al.
Publicado: (2022)